Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31424902 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRHPGDCA12KMT2A | |
| Hydrochloric Acid SCHEMBL8103680 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL6895483 | 0.91 | KMT2A (0.53) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL28613032 | 0.85 | ALDH1A1 (0.60) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL4373604 | 0.84 | ALDH1A1 (0.47) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL7783353 | 0.84 | ALDH1A1 (0.59) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL31628174 | 0.83 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL9826058 | 0.83 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL27859393 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDCA12KMT2A | |
| SCHEMBL448648 | 0.81 | ALDH1A1 (0.56) | ALDH1A1TSHRHPGDCA12KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3180307-A1 | PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES | Seegpharm SA (CH) | 2017-06-21 | — | — | EP | claimed |
| WO-2016016321-A1 | PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES | SEEGPHARM SA (CH) | 2016-02-04 | — | — | WO | claimed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| US-12583832-B2 | Cannabinoid analogs, formulations, and methods of use | NALU BIO, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-12576029-B2 | Noncompetitive receptor-targeted vaccine delivery to plasmacytoid dendritic cells | WASHINGTON UNIVERSITY (US) | 2026-03-17 | — | — | US | disclosed |
| US-20260001856-A1 | CANNABINOID ANALOGS, FORMULATIONS, AND METHODS OF USE | NALU BIO, INC. | 2026-01-01 | — | — | US | disclosed |
| US-20250340568-A1 | SOLID FORMS OF A MACROCYCLIC COMPOUNDS AS CFTR MODULATORS AND THEIR PREPARATION | VERTEX PHARMA (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250320226-A1 | METHODS OF PREPARING AND CRYSTALLINE FORMS OF (6A,12A)-17-AMINO-12-METHYL-6,15-BIS(TRIFLUOROMETHYL)-13,19-DIOXA-3,4,18-TRIAZATRICYCLO[12.3.1.12,5]NONADECA-1(18),2,4,14,16-PENTAEN-6-OL | VERTEX PHARMA (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250270181-A1 | SYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS, AND RELATED COMPOUNDS, FORMULATIONS, AND METHODS OF USE | NALU BIO, INC. | 2025-08-28 | — | — | US | disclosed |
| US-12264143-B2 | Synthesis of cannabinoids and cannabinoid precursors, and related compounds, formulations, and methods of use | NALU BIO, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| CN-119731183-A | Solid forms of macrocyclic compounds as CFTR modulators and their preparation | 弗特克斯药品有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-1994018165-A1 | SULFONAMIDE COMPOUNDS AS OPIOID K-RECEPTOR AGONISTS | PFIZER INC. (US) | 1994-08-18 | — | — | WO | disclosed |
| EP-0051466-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-01-09 | — | — | EP | disclosed |
| EP-0044209-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-10-31 | — | — | EP | disclosed |
| US-4454334-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-06-12 | — | — | US | disclosed |
| US-4420325-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1983-12-13 | — | — | US | disclosed |
| US-4397679-A | PREEMERGENCE, POSTEMERGENCE, PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-08-09 | — | — | US | disclosed |
| EP-0051466-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-05-12 | — | — | EP | disclosed |
| EP-0044209-A1 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12264143-B2 | Synthesis of cannabinoids and cannabinoid precursors, and related compounds, formulations, and methods of use | CNR2, CNR1, HMBS | ALDH1A1 3324/4885TSHR 2985/4885HPGD 130/4885 |
| US-12576029-B2 | Noncompetitive receptor-targeted vaccine delivery to plasmacytoid dendritic cells | DGKG, PHOSPHO1, TLR3 | ALDH1A1 4639/4885TSHR 1112/4885HPGD 2093/4885 |
| US-20250270181-A1 | SYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS, AND RELATED COMPOUNDS, FORMULATIONS, AND METHODS OF USE | CNR2, CNR1, HMBS | ALDH1A1 3324/4885TSHR 2985/4885HPGD 130/4885 |
| US-20250340568-A1 | SOLID FORMS OF A MACROCYCLIC COMPOUNDS AS CFTR MODULATORS AND THEIR PREPARATION | CFTR, SLC26A4, PKD1 | ALDH1A1 2754/4885TSHR 2266/4885HPGD 941/4885 |
| US-12583832-B2 | Cannabinoid analogs, formulations, and methods of use | CNR1, CNR2, CYP8B1 | ALDH1A1 1980/4885TSHR 2821/4885HPGD 244/4885 |
| US-20250320226-A1 | METHODS OF PREPARING AND CRYSTALLINE FORMS OF (6A,12A)-17-AMINO-12-METHYL-6,15-BIS(TRIFLUOROMETHYL)-13,19-DIOXA-3,4,18-TRIAZATRICYCLO[12.3.1.12,5]NONADECA-1(18),2,4,14,16-PENTAEN-6-OL | CFTR, PKD1, AQP1 | ALDH1A1 938/4885TSHR 3531/4885HPGD 578/4885 |
| US-20260001856-A1 | CANNABINOID ANALOGS, FORMULATIONS, AND METHODS OF USE | CNR2, CNR1, CTNND1 | ALDH1A1 3757/4885TSHR 1657/4885HPGD 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.